Navigation Links
Report recommends off-site disposal of secondary waste
Date:9/22/2007

WASHINGTON -- It is both technically feasible and advantageous for the U.S. Army's Chemical Materials Agency (CMA) to use off-site facilities to dispose of secondary waste during regular chemical agent disposal operations, says a new report from the National Research Council. The committee that wrote the report also determined that the provision in the Resource Conservation and Recovery Act allowing the submission of data from previous trial burns -- test runs required to prove the effectiveness of incinerators in destroying certain agents -- in lieu of new trial burns should be used to the fullest extent possible.

"The Army's incinerators are destroying the United States' stockpiled chemical weapons, but the on-site capacity is just not enough for treating high volumes of secondary wastes such as carbon, wood dunnage, or protective gear," said committee chair Peter B. Lederman, retired executive director of the Hazardous Substance Management Research Center, Newark, N.J. "Destroying the secondary waste concurrently at off-site locations whenever appropriate will dramatically improve closure operations."

The committee reviewed the waste disposal practices at all of CMA's currently operating incinerator facilities, located in Anniston, Ala., Pine Bluff, Ark., Umatilla, Ore., and Tooele, Utah, as well as the chemical neutralization facility in Newport, Ind. In evaluating the sites, the committee also drew from the experiences of the 2003 closure of the Johnston Atoll Chemical Agent Disposal System (JACADS) in the Pacific, which suffered from substantial increases in costs and delays due to thousands of tons of secondary waste that had accumulated on-site.

Current waste management at the facilities is regulated by state-issued permits that date back to before the construction of the facilities, when data concerning the quantities of wastes was scarce. While the permits have been modified somewhat since then, great disparity sti
'/>"/>

Contact: Paul Jackson
news@nas.edu
202-334-2138
The National Academies
Source:Eurekalert

Page: 1 2 3 4

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
3. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
4. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
5. Versatile Reporter Vectors for Monitoring Viral Transduction
6. In Vivo Signal Transduction Pathway Reporting Systems
7. Improved Vectors for PathDetect Trans-Reporting Systems
8. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
9. Cis-Reporting System Monitors Intracellular Calcium Mobilization
10. Cis-Reporting System Monitors Intracellular Calcium Mobilization
11. PatchMan - Test Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... Feb. 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... denying motions for judgment notwithstanding the verdict, a new ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... LA JOLLA, Calif. , Feb. 26, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and development ... Kleanthis G. Xanthopoulos , Ph.D., President and Chief Executive ... the Cowen and Company 35 th Annual Healthcare ... EST.  The conference is being held at the Boston ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... Staff; San Diego Office to Offer Regulatory ... Operations ... a,leader in providing software and services to streamline the drug,development lifecycle, ... a new facility in San Diego. The announcements,illustrate the company,s newly ...
... 58th Annual Meeting of the American ... TAMPA, Fla., Aug. 15 Romark Laboratories announced that,it ... (nitazoxanide) for,treating chronic hepatitis C in the United States. ... effectiveness and safety,of Alinia tablets administered in combination with ...
... Aug. 15 Barr,Pharmaceuticals, Inc. (NYSE: BRL ... has initiated a challenge of the patent listed ... Chilcott,s Femcon(R),FE (norethindrone and ethinyl estradiol) chewable oral ... to file an Abbreviated New Drug,Application (ANDA) containing ...
Cached Biology Technology:ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 2ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 3ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 4Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 2Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 3Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 4Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product 2Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product 3
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... include risk for heart attacks and strokes in addition ... MJ called delta-9-tetrahyrdocannabinol (THC) is believed to exert these ... several cell types in various organs. Scientists have ... heart, liver, kidney, and spleen. In this study, ...
... in social groups, and that includes humans, blindly following a ... this, animals have developed simple but effective behaviour to follow ... rather than follow a single group member. This ... of an individual as the group recognise that consensus is ...
... have an ambivalent relationship with light. They need it to ... of high-energy chemical intermediates that can injure or kill the ... conversion of sunlight into chemical energy cannot keep up with ... have anywhere to go because the system is jammed up ...
Cached Biology News:When following the leader can lead into the jaws of death 2When following the leader can lead into the jaws of death 3ASU researchers synthesize molecule with self-control 2
WTAP Antibody...
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
Biology Products: